Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Among authors: van calster b. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.
External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group.
Van Holsbeke C, Van Calster B, Valentin L, Testa AC, Ferrazzi E, Dimou I, Lu C, Moerman P, Van Huffel S, Vergote I, Timmerman D; International Ovarian Tumor Analysis Group. Van Holsbeke C, et al. Among authors: van calster b, van huffel s. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4440-7. doi: 10.1158/1078-0432.CCR-06-2958. Clin Cancer Res. 2007. PMID: 17671128 Clinical Trial.
Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.
Timmerman D, Van Calster B, Jurkovic D, Valentin L, Testa AC, Bernard JP, Van Holsbeke C, Van Huffel S, Vergote I, Bourne T. Timmerman D, et al. Among authors: van calster b, van huffel s, van holsbeke c. J Clin Oncol. 2007 Sep 20;25(27):4194-200. doi: 10.1200/JCO.2006.09.5943. Epub 2007 Aug 13. J Clin Oncol. 2007. PMID: 17698805
Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L, Pans S, Verschueren K, Van Calster B, Paridaens R, Westhovens R, Timmerman D, De Smet L, Vergote I, Christiaens MR, Neven P. Morales L, et al. Among authors: van calster b. J Clin Oncol. 2008 Jul 1;26(19):3147-52. doi: 10.1200/JCO.2007.15.4005. Epub 2008 May 12. J Clin Oncol. 2008. PMID: 18474874 Free article.
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
Vandenput I, Van Calster B, Capoen A, Leunen K, Berteloot P, Neven P, Moerman P, Vergote I, Amant F. Vandenput I, et al. Among authors: van calster b. Br J Cancer. 2009 Jul 21;101(2):244-9. doi: 10.1038/sj.bjc.6605157. Epub 2009 Jun 30. Br J Cancer. 2009. PMID: 19568245 Free PMC article.
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma.
Coosemans A, Van Calster B, Verbist G, Moerman P, Vergote I, Van Gool SW, Amant F. Coosemans A, et al. Among authors: van calster b, van gool sw. Int J Gynecol Cancer. 2011 Feb;21(2):302-8. doi: 10.1097/IGC.0b013e318207cab5. Int J Gynecol Cancer. 2011. PMID: 21734473 Free article.
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study.
Van Calster B, Valentin L, Van Holsbeke C, Zhang J, Jurkovic D, Lissoni AA, Testa AC, Czekierdowski A, Fischerová D, Domali E, Van de Putte G, Vergote I, Van Huffel S, Bourne T, Timmerman D. Van Calster B, et al. Among authors: van huffel s, van holsbeke c, van de putte g. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2420-8. doi: 10.1158/1055-9965.EPI-11-0422. Epub 2011 Sep 9. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21908724
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
Haest K, Kumar A, Van Calster B, Leunen K, Smeets A, Amant F, Berteloot P, Wildiers H, Paridaens R, Van Limbergen E, Weltens C, Janssen H, Peeters S, Menten J, Vergote I, Morlion B, Verhaeghe J, Christiaens MR, Neven P. Haest K, et al. Among authors: van calster b, van limbergen e. Ann Oncol. 2012 Jun;23(6):1449-54. doi: 10.1093/annonc/mdr478. Epub 2011 Oct 29. Ann Oncol. 2012. PMID: 22039079 Free article. Clinical Trial.
263 results